Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma

BACKGROUND: FOLFIRINOX stands a major breakthrough in the management of metastatic pancreatic adenocarcinoma (MPA). Nonetheless, significant side-effects have been reported using standard FOLFIRINOX. We aimed to compare survival outcomes, response rates and toxicity of patients treated with standard...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Gastrointest Oncol
Asıl Yazarlar: de Jesus, Victor Hugo Fonseca, Camandaroba, Marcos Pedro Guedes, Donadio, Mauro Daniel Spina, Cabral, Audrey, Muniz, Thiago Pimentel, de Moura Leite, Luciana, Sant’Ana, Lucas Ferreira
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6087866/
https://ncbi.nlm.nih.gov/pubmed/30151266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.04.02
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller